Norberto R Marfori, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4287 Oberlin Ave, Lorain, OH 44053 Phone: 440-282-4232 Fax: 440-282-5393 |
News Archive
Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that South Jersey Healthcare (SJH) Regional Medical Center has implemented Omnicell 14.0 with Anywhere RN(TM), a software solution used in conjunction with Omnicell's automated medication dispensing cabinets to ensure safe, efficient and accessible medication management throughout the hospital. South Jersey Healthcare was one of the first hospitals to implement Omnicell 14.0, which is now available to all Omnicell customers.
BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.
If you're 65 or older and taking more than four medications, resolve to talk to your doctor about doing a New Year's triage to make sure too many pills aren't making you sick, advises Milta Little, D.O., associate professor of geriatrics at Saint Louis University.
In his latest ad audit, Kaiser Health News staff writer Jordan Rau explores whether insurers' claims, made in a recent advertisement, add up.
The researchers selected the human adenovirus type 5 on which to base their vaccine because this replication-defective vector had already been used in their Ebola vaccine, with an excellent safety and immunogenicity profile in a phase 1 trial. The current study aimed to produce a vaccine that could offer mucosal vaccination and enhanced protection against this respiratory virus.
› Verified 7 days ago